Nuclera News

Read our latest press releases and news developments

Filter by

News Type

Blog
Company Announcements
General News
Investor News

Year

2021
2022
2023
2024
2025
2026

Open Filter

Company Announcements

Nuclera partners with Sharp Life Science advancing its digital microfluidics capability

February 7, 2024

Company Announcements

A first for the eProtein Discovery™ System at the University of Southampton

January 24, 2024

Company Announcements

Nuclera announces the appointment of Jonathan Milner as Chairman of the Board

January 8, 2024

General News

Nuclera enters into AI/ML protein design through a partnership with Google Cloud

December 19, 2023

General News

Nuclera awarded a Biomedical Catalyst Grant from Innovate UK with AI partner DeepMirror

December 6, 2023

Company Announcements

Nuclera unveils new Global Headquarters, One Vision Park

April 4, 2023

General News

Nuclera Announces Professor Michael Jewett as new member of the Scientific Advisory Board

October 24, 2022

General News

Announcing our new headquarters in Cambridge, UK

August 1, 2022

Investor News

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58M.

July 6, 2022

Company Announcements

Nuclera Announces Appointment of Colin Barnes and Kristine Friscino to its Executive Leadership Team

June 3, 2022

Pages: 1234

eProtein Discovery System

Automated multiplex protein screening system

Instrument

Cartridge

Reagents

Software

Nuclera News

FEATURED NEWS

Filter by

News Type

Year